BioCrea GmbH: BioCrea's Anti Depression Program Voted Top Neuroscience Project to Watch

BioCrea uses this expertise in an innovative multi-parameter optimization approach to generate and deliver CNS drug candidates that offer significant potential for greater efficacy and tolerability. [...]the patient-derived stem cell (iPSC) platform has been successfully developed to discover high v...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	DGAP Deutsche Gesellschaft für Ad-hoc-Publizität. Corporate News
Médium:	Newsletter
Jazyk:	angličtina
Vydáno:	Munich EQS Group AG 18.11.2014
Vydání:	English ed.
Témata:	Amyotrophic lateral sclerosis Meetings Neurosciences Pharmaceutical industry
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Popis
Shrnutí:	BioCrea uses this expertise in an innovative multi-parameter optimization approach to generate and deliver CNS drug candidates that offer significant potential for greater efficacy and tolerability. [...]the patient-derived stem cell (iPSC) platform has been successfully developed to discover high value preclinical drug candidates for neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease).